Detect and Prevent Duplicate Subjects in Clinical Trials: A Global Challenge
The integrity of clinical trials is paramount to ensuring reliable results, patient safety, and regulatory compliance. However, duplicate subjects in clinical trials—individuals who enroll in multiple studies simultaneously or in rapid succession—pose a significant risk to data accuracy and patient safety. The issue is not confined to specific regions such as Florida or California or
Practices to Detect and Prevent Cross Sponsor Duplicate Subjects in Clinical Trials
The integrity of clinical trials hinges on ensuring that each participant is unique to the study and does not enroll multiple times in the same trial or across different studies. Duplicate research subjects introduce significant risks, compromising data validity, regulatory compliance, and overall study success. While detection efforts at the study’s conclusion can identify such
ProofPilot and Verified Clinical Trials Announce Strategic Partnership to Scale Participant Integrity in Clinical Trial Recruitment
NEW YORK, March 19, 2024 /PRNewswire/ — ProofPilot, the industry’s only platform for clinical trial automation, guidance and flawless execution, is excited to announce its strategic partnership with Verified Clinical Trials (VCT), the world’s leading validated research participant registry and verification platform. This collaboration marks a significant milestone in improving data integrity by reducing the risk of ineligible patients. VCT
Mitigating the Effects of Nonadherence in Clinical Trials by Preventing Duplicate Subjects in Clinical Trials
Nonadherence in clinical trials remains a significant hurdle, leading to compromised data integrity, skewed results, and costly delays. One often overlooked but critical factor contributing to nonadherence is the presence of duplicate subjects and professional research subjects—individuals who enroll in multiple trials simultaneously or misrepresent their participation history. The Hidden Impact of Duplicate Subjects Nonadherence
The Growing Obesity Epidemic, Clinical Trials, and the Rising Challenge of Duplicate Subjects
The global obesity epidemic continues to surge, leading to an unprecedented demand for effective treatments and numerous clinical trials. As a result, the clinical trial landscape is rapidly expanding, with numerous companies conducting a wide array of obesity-related studies. Among these, GLP-1 receptor agonists have emerged as a leading therapeutic option, prompting a significant increase
How to Avoid The Dangers of Duplicate Participants in Clinical Trials
The prevalence of duplicate participants in clinical trials poses significant risks, compromising the integrity of data and the safety of the patients involved. To delve into this matter, we spoke with Kerri Weingard, a seasoned veteran in the field and the co-founder of Verified Clinical Trials (VCT), who brings a wealth of knowledge and experience. In this
